Streetbeat News

Stock Prices

HUMA

Humacyte (NASDAQ:HUMA) is set to release its latest quarterly earnings report on Monday, 2023-08-14. Analysts estimate an earnings per share (EPS) of $-0.22. The company's past performance shows a trend of missing EPS estimates, which has generally led to a drop in share price. Shares of Humacyte were trading at $3.41 as of August 10, with a 52-week drop of 29.92%.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

BCLI

Brainstorm Cell (NASDAQ:BCLI) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.15. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $1.62, down 53.3% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

MNDY

Monday.Com (NASDAQ:MNDY) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $0.14. The company's past performance shows a pattern of beating EPS estimates, but this has not always led to a rise in share price. The stock is currently trading at $155.32 and has seen a 13.77% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:01 pm

ERJ

Embraer (NYSE:ERJ) is set to release its quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $0.12. The company's past performance shows a mixed trend of beating and missing EPS estimates, which has led to varying impacts on the share price. Embraer's shares were trading at $14.76 as of August 10, with a 26.16% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

HUBB

Over the last quarter, Hubbell (NYSE:HUBB) has received mixed analyst ratings, with 1 somewhat bullish, 3 indifferent, and 1 bearish. The average price target among these analysts is $326.6, indicating potential upside from the current price of $309.0. The average price target has increased by 18.01% over the past month.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

RCKT

Rocket Pharmaceuticals (NASDAQ:RCKT) has received five bullish analyst ratings in the last quarter, with an average 12-month price target of $55.2, an increase of 8.24% over the past month. No bearish or indifferent ratings were observed.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

HLLY

Over the past three months, 13 analysts have published their opinion on Holley (NYSE:HLLY) stock. The majority of these ratings are bullish, with an average price target of $6.85, which is lower than the current price of $7.54. This average price target has increased by 37.83% from the previous average of $4.97.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

CERT

Analysts have provided ratings for Certara (NASDAQ:CERT) within the last quarter, with one somewhat bullish and three indifferent. The average price target is $73.5, implying an upside from the current price of $16.57. This average has increased by 1.03% from the previous average price target of $72.75.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

PAYX

Over the past 10 years, Paychex (NASDAQ:PAYX) has outperformed the market by 1.8% on an annualized basis, producing an average annual return of 12.11%. If an investor had bought $100 of PAYX stock 10 years ago, it would be worth $309.95 today. The company currently has a market capitalization of $44.72 billion.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm

SVV

Savers Value Village (NYSE:SVV) has received positive analyst ratings in the last quarter, with 8 bullish and 4 somewhat bullish ratings. The average 12-month price target for SVV is $28.25, which has increased by 4.63% over the past month.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 2:00 pm